151 related articles for article (PubMed ID: 31635652)
21. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
[TBL] [Abstract][Full Text] [Related]
22. Preparation and in-vitro evaluation of mesoporous biogenic silica nanoparticles obtained from rice and wheat husk as a biocompatible carrier for anti-cancer drug delivery.
Porrang S; Rahemi N; Davaran S; Mahdavi M; Hassanzadeh B
Eur J Pharm Sci; 2021 Aug; 163():105866. PubMed ID: 33957220
[TBL] [Abstract][Full Text] [Related]
23. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
24. An Adjustable pH-Responsive Drug Delivery System Based on Self-Assembly Polypeptide-Modified Mesoporous Silica.
Yang C; Shi Z; Feng C; Li R; Luo S; Li X; Ruan L
Macromol Biosci; 2020 Jun; 20(6):e2000034. PubMed ID: 32329202
[TBL] [Abstract][Full Text] [Related]
25. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.
Tu J; Du G; Reza Nejadnik M; Mönkäre J; van der Maaden K; Bomans PHH; Sommerdijk NAJM; Slütter B; Jiskoot W; Bouwstra JA; Kros A
Pharm Res; 2017 Aug; 34(8):1693-1706. PubMed ID: 28536970
[TBL] [Abstract][Full Text] [Related]
26. Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles.
Zhou M; Zhao Q; Wu Y; Feng S; Wang D; Zhang Y; Wang S
AAPS PharmSciTech; 2020 Jan; 21(2):42. PubMed ID: 31897882
[TBL] [Abstract][Full Text] [Related]
27. Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency.
Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111239. PubMed ID: 32806268
[TBL] [Abstract][Full Text] [Related]
28. Mesoporous Silicon Nanoparticles with Liver-Targeting and pH-Response-Release Function Are Used for Targeted Drug Delivery in Liver Cancer Treatment.
Wei J; Tan Y; Bai Y; He J; Cao H; Guo J; Su Z
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473773
[TBL] [Abstract][Full Text] [Related]
29. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.
Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H
Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882
[TBL] [Abstract][Full Text] [Related]
30. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel.
He Y; Liang S; Long M; Xu H
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():12-17. PubMed ID: 28575958
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles.
Zhang J; Li X; Rosenholm JM; Gu HC
J Colloid Interface Sci; 2011 Sep; 361(1):16-24. PubMed ID: 21689824
[TBL] [Abstract][Full Text] [Related]
32. Folate-Conjugated pH-Responsive Nanocarrier Designed for Active Tumor Targeting and Controlled Release of Gemcitabine.
Pourjavadi A; Tehrani ZM; Moghanaki AA
Pharm Res; 2016 Feb; 33(2):417-32. PubMed ID: 26438181
[TBL] [Abstract][Full Text] [Related]
33. Delivery of curcumin by fucoidan-coated mesoporous silica nanoparticles: Fabrication, characterization, and in vitro release performance.
Zhang X; Zhu Y; Fan L; Ling J; Yang LY; Wang N; Ouyang XK
Int J Biol Macromol; 2022 Jun; 211():368-379. PubMed ID: 35577185
[TBL] [Abstract][Full Text] [Related]
34. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
[TBL] [Abstract][Full Text] [Related]
35. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
[TBL] [Abstract][Full Text] [Related]
36. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
37. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
38. Smart MSN-Drug-Delivery System for Tumor Cell Targeting and Tumor Microenvironment Release.
Dong JH; Ma Y; Li R; Zhang WT; Zhang MQ; Meng FN; Ding K; Jiang HT; Gong YK
ACS Appl Mater Interfaces; 2021 Sep; 13(36):42522-42532. PubMed ID: 34463488
[TBL] [Abstract][Full Text] [Related]
39. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
[TBL] [Abstract][Full Text] [Related]
40. Effects of pore size on
Li J; Shen S; Kong F; Jiang T; Tang C; Yin C
RSC Adv; 2018 Jul; 8(43):24633-24640. PubMed ID: 35539161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
